PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Cataracts, an eye condition in which the lens becomes cloudy and impairs vision, affect more people than you might think. According to the nonprofit organization Prevent Blindness, over 25 million ...
The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the ...
The FINANCIAL — Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the ...
SCOTTSDALE, Ariz., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Horizon Eye Specialists & Lasik Center, the leading comprehensive eye care center in Arizona, today announces it has started offering the latest ...
GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
LAKE CHARLES, La. (KPLC) - Cataracts affect more than 24 million Americans over the age of 40, but now those in the U.S have the chance to try a new FDA approved lens. Over the last few years, Steve ...
More than three million cataract surgeries performed in Europe annually[1] Basel, Switzerland, June 16, 2015 - Alcon, the global leader in eye care and a division of Novartis, has received European CE ...
SIOUX FALLS, S.D., Sept. 10, 2019 /PRNewswire/ -- More than four million cataract surgeries are performed each year in the U.S. and the number is projected to increase by more than sixteen percent by ...
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results